Our #WIN332 work is out! 🥳 rdcu.be/e15ti
In this study, led by Ignacio R. Relano, we report WIN332, the first engineered HIV-1 Env immunogen rationally designed to induce a new class of #TypeII #N332-glycan independent #V3-glycan antibodies. #THANKYOU to our collaborators for a great team effort!
2
0
1
0